Sputnik V, the third anti-coronavirus vaccine approved for use in India, for the public at its Gurgaon facility - Fortis Memorial Research Institute.
Sputnik V uses two different viruses that cause the common cold (adenovirus) in humans. The two doses, given 21 days apart, are different and not interchangeable.
This comes hours after several reports confirmed that the roll-out of the Russian vaccine 'Sputnik V' at various private hospitals in the Delhi-NCR region has been delayed. "We do not have a clarity on the dates of the vaccine roll-out," a spokesman of Apollo Hospitals said.
Indraprastha Apollo here had earlier said that it would tentatively start administering the two-dose vaccine by June 25. An official of Madhukar Rainbow